Current Opinion in Cardiology was launched in 1985. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of cardiology is divided into 14 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue.
Dr Subodh Verma is an internationally renowned cardiac surgeon-scientist and Professor at the University of Toronto, Canada. He is the Canada Research Chair in Cardiovascular Surgery and former recipient of the Howard Morgan Award for Distinguished Achievements in Cardiovascular Research and the Royal College of Physicians and Surgeons of Canada Gold Medal in Surgery. He is a member of the American Association of Thoracic Surgeons (AATS) and the College of New Scholars, Artists and Scientists, Royal Society of Canada. Dr Verma has an h-index of 67, with nearly 18,000 total citations to 385 publications.
Dr Verma has co-authored two state-of-the-art NEJM reviews on mitral valve repair and bicuspid aortopathy. His surgical-centric meta-analysis has been used by the American College of Cardiology and the Canadian Cardiovascular Society (CCS) to shape the recommendations for best revascularization choice in individuals with diabetes. He was/is a contributor to several CCS guidelines and is an author of the 2018 Diabetes Canada guidelines and the 2018 AATS consensus guidelines on bicuspid aortic valve-related aortopathy. Dr Verma has served on the American Heart Association Council on Cardiovascular Surgery and Anesthesia since 2008.
Dr Verma's clinical trial work focuses on diabetes, dyslipidemia and heart failure. He has leadership roles (Steering Committee and/or National Coordinator) on all 5 of the ongoing global heart failure trials in diabetes – Dapa-HF, DELIVER, EMPEROR-Preserved, EMPEROR-Reduced and SOLOIST-WHF. Dr Verma is also the National Coordinator of the international SELECT (semaglutide) trial and sits on the Steering Committee of the CLEAR SYNERGY (OASIS 9) trial. Locally at St Michael's Hospital, Canada, he spearheads the CARDIOLINK clinical trials platform.
Dr Verma oversees a pre-clinical research team that focuses on identifying novel biomarkers in cardiovascular health and developing innovative cardiovascular remedies. This program has yielded 2 United States patents and is supported by the Canadian Foundation for Innovation, Canadian Institutes of Health Research (CIHR) and Heart & Stroke Foundation (HSF).
Bobby Yanagawa is Assistant Professor and Program Director, Division of Cardiac Surgery at the University of Toronto, Canada. Dr Yanagawa's clinical and research interests are surgical revascularization and valvular heart disease. Dr Yanagawa obtained his BSc and PhD from the University of British Columbia, Canada, and his MD degree and Cardiac Surgery Residency from the University of Toronto. He has completed research fellowships at the University of Wales College of Medicine (Cardiff, UK), National Cardiovascular Center (Osaka, Japan) and at St Michael's Hospital (Toronto, Canada). He completed an advanced valvular fellowship at Mount Sinai Hospital, New York, USA. He has published over 60 peer reviewed papers, 40 reviews and 15 book chapters including publications in Nat Comm, Nat Med, Circulation, JACC and JTCVS. He was the AATS 13th Annual C. Walton Lillehei Award winner in 2010.
Dr Haddad received his BSc degree from Tichreen University in Syria in 1980 and graduated from Medical School at Tichreen University in 1983. Following a family medicine practice in Syria, Dr Haddad immigrated to Canada and trained in Internal Medicine at Dalhousie University, Canada, and successfully completed his Cardiology training at the University of Alberta, Canada.
In July 1997, Dr Haddad joined the Division of Cardiology, Queen Elizabeth II Health Sciences Centre, Dalhousie University in Halifax, Nova Scotia and was Medical Director of the Heart Transplant Program and Director of the Cardiac Rehabilitation Program.
In September 2001, Dr Haddad joined the University of Ottawa Heart Institute; he is the professor of Medicine, Division of Cardiology and was the Director of the Heart Failure Program, and Medical Director of Heart Transplant Program from 2001 to 2014. He was also an Adjunct Professor in the Department of Systems and Computer Engineering at Carleton University in Ottawa, Canada (2003–2016)
Dr Haddad is a member of the Panel of the Canadian Cardiovascular Society's consensus conferences on the management of heart failure (2001–2016), on heart transplantation in adults (2003) and on heart transplantation in pediatrics (2005). He also chaired the Society's consensus conference for heart transplant in 2008.
Dr Haddad has earned numerous prestigious awards, namely the Anemia Institute for Research and Education Award in 2005, and the 1st Award Prize in the International Competition of the American College of Physicians in 2000. He was elected as Chair of the Board of Directors to the Canadian Heart Failure Society in April 2015. In April 2016, he moved to Saskatchewan where he is the Head Department of Medicine, University of Saskatchewan, Canada, and Provincial Head in Medicine.